An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis
Clinical trial NCT01008696 · COMPLETED
Trial details
- NCT number
- NCT01008696
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2008-08-01
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.